COVID-19: an update on the epidemiological, clinical, preventive, and therapeutic management of 2019 novel coronavirus disease

O Ashraf, A Virani, T Cheema - Critical care nursing quarterly, 2021 - journals.lww.com
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus (SARS-
CoV-2) remains a serious issue for global health, given widespread infectivity and a high …

Coronavirus diseases (COVID-19) current status and future perspectives: A narrative review

FD Gennaro, D Pizzol, C Marotta, M Antunes… - IJERPH, 2020 - econpapers.repec.org
At the end of 2019 a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China …

Clinical observation and management of COVID-19 patients

T Li, H Lu, W Zhang - Emerging microbes & infections, 2020 - Taylor & Francis
Three leading infectious disease experts in China were invited to share their bedside
observations in the management of COVID-19 patients. Professor Taisheng Li was sent to …

One-year multidisciplinary follow-up of patients with COVID-19 requiring invasive mechanical ventilation

A Zangrillo, A Belletti, D Palumbo, MR Calvi… - … of Cardiothoracic and …, 2022 - Elsevier
Objectives Patients with COVID-19 frequently develop acute respiratory distress syndrome
(ARDS) requiring intensive care unit (ICU) admission. Data on long-term survival of these …

[HTML][HTML] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)–anatomic pathology perspective on current …

SK Mohanty, A Satapathy, MM Naidu… - Diagnostic …, 2020 - Springer
Background The world is currently witnessing a major devastating pandemic of Coronavirus
disease-2019 (COVID-19). This disease is caused by a novel coronavirus named Severe …

[HTML][HTML] Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study …

LF Reyes, A Rodriguez, YV Fuentes, S Duque… - Scientific reports, 2023 - nature.com
Around one-third of patients diagnosed with COVID-19 develop a severe illness that
requires admission to the Intensive Care Unit (ICU). In clinical practice, clinicians have …

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

X Wu, X Liu, Y Zhou, H Yu, R Li, Q Zhan… - The Lancet …, 2021 - thelancet.com
Background The consequences of COVID-19 in those who recover from acute infection
requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal …

[HTML][HTML] Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore

SH Puah, BE Young, PY Chia, VK Ho, J Loh… - Scientific reports, 2021 - nature.com
We aim to describe a case series of critically and non-critically ill COVID-19 patients in
Singapore. This was a multicentered prospective study with clinical and laboratory details …

[HTML][HTML] Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians

SS Batah, AT Fabro - Respiratory medicine, 2021 - Elsevier
COVID-19 has quickly reached pandemic levels since it was first reported in December
2019. The virus responsible for the disease, named SARS-CoV-2, is enveloped positive …

Clinical characteristics of SARS-CoV-2 pneumonia compared to controls in Chinese Han population

Y Xu, Y Li, Q Zeng, Z Lu, Y Li, W Wu, S Dong, G Huang… - MedRxiv, 2020 - medrxiv.org
Abstract Background In December 2019, novel coronavirus (SARS-CoV-2) infected
pneumonia occurred in Wuhan, China. The number of cases has increased rapidly but …